MIO-CPP to Improve the Well-being, Permanency, and Safety Outcomes for Young Children at Risk of or in Out-of-home Placement in Philadelphia and Bucks Counties, and Affected by Maternal Substance Use
Substance Use Disorders, Parent-Child Relations, Parent Child Abuse
About this trial
This is an interventional treatment trial for Substance Use Disorders focused on measuring Child-parent therapy, Reflective parenting, Trauma-informed care
Eligibility Criteria
Inclusion Criteria:
- Women actively receiving treatment for Substance Use Disorder at one of three participating clinics in Philadelphia and Bucks Counties: Libertae Inc.; The Caring Together Program; Interim House West; the Neonatal Follow-up Program at CHOP; Penn Family Care; the Temple Opioid Program; the Maternal, Child, and Family Health Doula Support Program; and the Einstein Hospital Perinatal Substance Use Team
- Must be at least six months pregnant or must have a child 5 years old or younger.
- Must have access to child - children must either reside with mother, or, if the child is in foster/kinship care, the goal must be reunification.
Exclusion Criteria:
- At Libertae Inc. and Interim House West (both residential treatment facilities), women will not be referred for enrollment before they have been affiliated with the treatment facility for at least 14 days and will not be referred if they are less than 45 days from discharge.
- At Caring Together (an outpatient clinic), women will not be referred to the study before they have completed 2 weeks of outpatient visits. This minimum will ensure that women are not enrolled before their substance use treatment has begun.
- The study will not enroll mothers who would be unable to receive the intervention services in English without the assistance of an interpreter. Due to the duration of the study intervention as well as the frequency of visits between the Child-Parent Specialist and the client, it would not be feasible to ensure that an interpreter would also be available for all visits.
Sites / Locations
- Roberts Center for Pediatric Research
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
MIO-CPP
MIO-CPP-CRS
The 9 month MIO-CPP model will begin with the standard 12 weeks of MIO for each mother, with the CPP assessment and engagement phase embedded during this time. This phase will be followed by the dyadic mother-child phase, the core intervention stage of CPP. If a parent needs additional stabilization, more individual time can be added. During the core phase of dyadic CPP the Child Parent Specialists will continue to build and strengthen parents' reflective functioning by embedding aspects from MIO. The 9 month MIO-CPP model will begin with the standard 12 weeks of MIO for each mother, with the CPP assessment and engagement phase embedded during this time. This phase will be followed by the dyadic mother-child phase, the core intervention stage of CPP. If a parent needs additional stabilization, more individual time can be added.
In Phase 2, participants will receive MIO-CPP therapy, as well as support from a CRS. The MIO-CPP model will begin with 6 sessions of MIO for each study participant, with the CPP assessment and engagement phase embedded during this time. This phase will be followed by the dyadic mother-child phase, the core intervention stage of CPP. If a parent needs additional stabilization, more individual time can be added. During the core phase of dyadic CPP the Child Parent Specialists will continue to build and strengthen parents' reflective functioning by embedding aspects from MIO. Participant dyads will be assigned a Certified Recovery Specialists (CRSs) who will provide services to support them as they transition out of SUD treatment and back into their home communities.